Search Results - "Tarbell, Nancy J."

Refine Results
  1. 1
  2. 2
  3. 3

    Incidence of Second Malignancies Among Patients Treated With Proton Versus Photon Radiation by Chung, Christine S., MD, MPH, Yock, Torunn I., MD, MCh, Nelson, Kerrie, PhD, Xu, Yang, MS, Keating, Nancy L., MD, MPH, Tarbell, Nancy J., MD

    “…Purpose Proton radiation, when compared with photon radiation, allows delivery of increased radiation dose to the tumor while decreasing dose to adjacent…”
    Get full text
    Journal Article
  4. 4

    High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031) by TARBELL, Nancy J, FRIEDMAN, Henry, POLKINGHORN, William R, YOCK, Torunn, TIANNI ZHOU, ZHENGJIA CHEN, BURGER, Peter, BARNES, Patrick, KUN, Larry

    Published in Journal of clinical oncology (10-08-2013)
    “…To compare event-free survival (EFS) in children with high-risk medulloblastoma randomly assigned to receive either chemotherapy before radiation or…”
    Get full text
    Journal Article
  5. 5

    The “Gender Gap” in Authorship of Academic Medical Literature — A 35-Year Perspective by Jagsi, Reshma, Guancial, Elizabeth A, Worobey, Cynthia Cooper, Henault, Lori E, Chang, Yuchiao, Starr, Rebecca, Tarbell, Nancy J, Hylek, Elaine M

    Published in The New England journal of medicine (20-07-2006)
    “…In this study of research published in six prominent medical journals, the proportion of female first authors increased from 6 percent in 1970 to 29 percent in…”
    Get full text
    Journal Article
  6. 6

    Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors by Pulsifer, Margaret B., PhD, Sethi, Roshan V., MD, Kuhlthau, Karen A., PhD, MacDonald, Shannon M., MD, Tarbell, Nancy J., MD, Yock, Torunn I., MD

    “…Purpose To report, from a longitudinal study, cognitive outcome in pediatric patients treated with proton radiation therapy (PRT) for central nervous system…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma by Ladra, Matthew M, Szymonifka, Jackie D, Mahajan, Anita, Friedmann, Alison M, Yong Yeap, Beow, Goebel, Claire P, MacDonald, Shannon M, Grosshans, David R, Rodriguez-Galindo, Carlos, Marcus, Karen J, Tarbell, Nancy J, Yock, Torunn I

    Published in Journal of clinical oncology (20-11-2014)
    “…This prospective phase II study was designed to assess disease control and to describe acute and late adverse effects of treatment with proton radiotherapy in…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Delayed Diagnosis in Children with Intracranial Germ Cell Tumors by Sethi, Roshan V., BS, Marino, Rose, MD, Niemierko, Andrzej, PhD, Tarbell, Nancy J., MD, Yock, Torunn I., MD, MacDonald, Shannon M., MD

    Published in The Journal of pediatrics (01-11-2013)
    “…Objective To review symptoms and provider history in a large cohort of patients with germ cell tumors (GCTs) to highlight the variety of manifestations and…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Use of proton therapy for re-irradiation in pediatric intracranial ependymoma by Eaton, Bree R, Chowdhry, Varun, Weaver, Kenneth, Liu, Li, Ebb, David, MacDonald, Shannon M, Tarbell, Nancy J, Yock, Torunn I

    Published in Radiotherapy and oncology (01-08-2015)
    “…Abstract Background and purpose To report disease control, survival and treatment-associated toxicity with the use of proton therapy (PRT) for re-irradiation…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Secondary Malignancy Risk Following Proton Radiation Therapy by Eaton, Bree R, MacDonald, Shannon M, Yock, Torunn I, Tarbell, Nancy J

    Published in Frontiers in oncology (26-11-2015)
    “…Radiation-induced secondary malignancies are a significant, yet uncommon cause of morbidity and mortality among cancer survivors. Secondary malignancy risk is…”
    Get full text
    Journal Article
  19. 19
  20. 20